INEX Innovate at MEDICA 2022 Dusseldorf to showcase the OvaCis® Rapid Test Kit – the world’s first intraoperative rapid test to effectively discriminate benign from malignant ovarian cysts.

By Ricky LimNovember 8, 2022November 14th, 2022No Comments

INEX Innovate at MEDICA 2022 Dusseldorf to showcase the OvaCis® Rapid Test Kit – the world’s first intraoperative rapid test to effectively discriminate benign from malignant ovarian cysts.

https://www.linkedin.com/posts/inex-innovate_cancer-cancerdiagnostics-earlycancerdetection-activity-6995631127155679233-Qivm/?utm_source=share&utm_medium=member_ios

Let's shake the diagnostics status quo and put scientific discoveries into clinical practice

Partnerships are vital for continued medical advancements. We constantly seek collaborators to:

Support existing research and clinical programmes

Diversify our portfolio with new technology in women’s and reproductive health

Accelerate the development of innovative diagnostics tools

Let's work together to improve the lives of women around the world.

Head Office

6 Raffles Quay
#14-04/05
Singapore 048580

Laboratory

1 Science Park Road
#04-10 The Capricorn
Singapore 117528

Connect

Please note that the contents of this website are for corporate and non-commercial information purposes only and are provided on the understanding that no surgical or medical advice or recommendation is being rendered. Please refer to our website Terms of Use. The content of this site may not be construed as advertisements for any product or service that INEX or any of its subsidiary companies offers.

INEX Innovate at MEDICA 2022 Dusseldorf to showcase the OvaCis® Rapid Test Kit – the world’s first intraoperative rapid test to effectively discriminate benign from malignant ovarian cysts.